Filter posts

BIO Official Bloggers Preview the Convention

Want to know what to expect at the 2012 BIO International Convention? Find out from …

Your Social Media Guide to #BIO2012

The BIO International Convention is the largest global event for the biotechnology industry; it attracts …

Picks and Pans – The Buy-Side View for 2012

What’s the forecast for biotech in 2012? Do investors think it is a good time …

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s …

Fireside Chat with Moncef Slaoui, GlaxoSmithKline

Moncel Slaoui, chairman of research and development (R&D) at GlaxoSmithKline (GSK), opened the 2012 BIO …

NIH: Streamlining the Technology Transfer Process

The National Institutes of Health (NIH) is launching the electronic Research Materials catalogue (eRMa) to …

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

Insights in to the molecular and genetic basis of disease are driving new product and …

Reverse Mergers: A Company is Ready to Go Public, or it’s Not

The latest IPO window has stalled. There have been five IPO withdrawals since June and …

Increasing Partnering at BIO

Mike May from Biotech Tallies writes: At the 2011 BIO International Convention, the number of …

Stopping ALS: An interview with Dr. Perrin from ALS TDI

What is ALS? How widespread is the disease? Are there any treatments for ALS? Amyotrophic …